Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Valacyclovir treatment, administered during
pregnancy after proven primary maternal Cytomegalovirus (CMV) infection, reduces fetal
transmission rates and prevents fetal injury in cases of fetal infection.